Application

18104578 · METHODS AND KITS FOR PREDICTING INFUSION REACTION RISK AND ANTIBODY-MEDIATED LOSS OF RESPONSE BY MONITORING SERUM URIC ACID DURING PEGYLATED URICASE THERAPY

Filed 2023-02-01 · Granted · Patent 11982670 (2024-05-14) The official file ↗The patent and its PDF ↗ · Art unit 1657 · Examiner Satyendra K Singh Typical · CPC A61M 5/168 · Horizon Therapeutics USA, Inc. · COOLEY LLP / Horizon Therapeutics PLC

Office actions

first was Notice of allowance

RCEs

no appeal

To first action

11.2 mo

to disposition 15.4 mo

Statutes raised

0 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.